Rep. Kevin Hern (R-Okla.) has filed a Periodic Transaction Report disclosing the sale of Biogen Inc. (BIIB) common stock, according to records submitted to the U.S. House of Representatives under the STOCK Act. The transaction, dated August 18, 2026, was made personally by Hern and held through his Kevin Hern Traditional IRA. The disclosed value … Read more
This page follows Sofinnova Investments, Inc.’s institutional portfolio as disclosed in its quarterly Form 13F filings with the SEC. A Form 13F is a required filing for institutional investment managers overseeing more than $100 million in U.S. equities, and it offers a snapshot of long positions held at the end of each quarter — not … Read more